← Leaderboards
William Perry
University Of California San Diego
$5,104,942
Attributed
$7,927,727
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $684.1K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,927,727 · 3
By mechanism
R01$7,510,777 · 2
R21$416,950 · 1
Top collaborators
- Jared William Young8 shared
- Mark A Geyer5 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- John R Kelsoe$20,313,733
- Thomas Beach Barrett$1,290,897
- Mark A Geyer$12,360,665
- Sidney Zisook$3,342,148
- Dilip V Jeste$42,629,237
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineNeurotransmittersBehavioralBipolar DisorderBaseRegulationRodentManicFunctional DisorderBehaviorDopamine TransporterDecision MakingMouse ModelBrainImpairmentCognitiveCognitive DeficitsAcuteNeurobiologyChronicAttenuatedReportingPrefrontal CortexPrepulse Inhibition
Grant awards (20)
Cannabis use and the endocannabinoid system in bipolar disorder$575,924
R01 · FY2022 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$50,584
R01 · FY2022 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$595,332
R01 · FY2021 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$88,788
R01 · FY2021 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$619,160
R01 · FY2020 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$50,395
R01 · FY2020 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$620,619
R01 · FY2019 · DA · contact PI
Cannabis use and the endocannabinoid system in bipolar disorder$665,803
R01 · FY2018 · DA · contact PI
INHIBITORY DEFICITS IN HUMAN AND ANIMAL MODELS OF BIPOLAR DISORDER$479,753
R01 · FY2014 · MH · contact PI
INHIBITORY DEFICITS IN HUMAN AND ANIMAL MODELS OF BIPOLAR DISORDER$460,442
R01 · FY2013 · MH · contact PI
Endocannabinoid system and inhibition in bipolar disorder$223,200
R21 · FY2013 · MH · contact PI
INHIBITORY DEFICITS IN HUMAN AND ANIMAL MODELS OF BIPOLAR DISORDER$479,832
R01 · FY2012 · MH · contact PI
Endocannabinoid system and inhibition in bipolar disorder$193,750
R21 · FY2012 · MH · contact PI
INHIBITORY DEFICITS IN HUMAN AND ANIMAL MODELS OF BIPOLAR DISORDER$476,019
R01 · FY2011 · MH · contact PI
INHIBITORY DEFICITS IN HUMAN AND ANIMAL MODELS OF BIPOLAR DISORDER$482,920
R01 · FY2010 · MH · contact PI
Inhibitory Deficits in Mania and Hyperdopaminiergic Mice$366,235
R01 · FY2008 · MH · contact PI
Inhibitory Deficits in Mania and Hyperdopaminiergic Mice$366,235
R01 · FY2007 · MH · contact PI
Inhibitory Deficits in Mania and Hyperdopaminiergic Mice$377,173
R01 · FY2006 · MH · contact PI
Inhibitory Deficits in Mania and Hyperdopaminiergic Mice$385,000
R01 · FY2005 · MH
Inhibitory Deficits in Mania and Hyperdopaminiergic Mice$370,563
R01 · FY2004 · MH